Figure 3.
Crude overall survival of patients who received palliative chemotherapy for metastatic pancreatic cancer, by age group. Survival calculated from date of starting chemotherapy (77% of patients). Log rank test P = 0.006.
Crude overall survival of patients who received palliative chemotherapy for metastatic pancreatic cancer, by age group. Survival calculated from date of starting chemotherapy (77% of patients). Log rank test P = 0.006.